Obermatt
See Similar Stocks →

Flags

Financial distress

Emeis

PAR:EMEIS · FR001400NLM4
Health Care Providers & ServicesLarge

360

15
EV / EBIT14
Price / Owner Earnings58
Owner Earnings Yield43
Dividend Yield1
Price/Sales91
EV / Gross Profit22
Price/Book70
Return on Capital15
Cash Return on Capital38
Return on Equity4
EBIT Margin9
Gross Profitability9
Accruals93
Owner Earnings Margin37
Sales growth42
Profit Growth17
Long-Term EPS Growth31
Owner Earnings Growth83
Reinvestment51
Price momentum87
Debt load1
Refinancing8
Debt Payback17
Liquidity22
Analyst ratings11
Opinion Changes11
Price Target Upside19
Market mood13
Value Creation12/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Emeis clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Profile

CountryFrance
IndustryHealth Care Providers & Services
SizeLarge
TypePublic Company
ExchangeENXTPA
Founded1995
Employees1,889
Websiteemeis.fr
ISINFR001400NLM4
Last UpdateApr 2, 2026
Indices
CAC All (France)SBF 120 (France)
Themes
PsychiatryCardiovascularChronic DiseasesNeurologyAssisted LivingCentral Nervous SystemHealth CareHome Health CareHospitalMedicalMental HealthNursing and Residential Care

Description

Analysis

Middle-of-the-road

emeis Société anonyme is a middle-of-the-road business: neither the economics nor the price stand out from the peer group.

The price is attractive. You pay 13.0× its owner earnings: the cash an owner could take out each year, which is in the historically attractive zone.

The trajectory is solid and the balance sheet is fragile. The company scores 12/20 on our value-creation score: creating some value. Analyst sentiment is cautious.

Nothing is flagged here: no red or amber gates, no divergence between profits and cash. That is itself information: the numbers are straightforward. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
14
2023202420252026

All-time high

28

Mar 2026

All-time low

1

Jan 2025

Average rank

14

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
91
91
79
64
Price/Earnings
100
100
100
70
Price/Book
70
86
100
77
Dividend Yield
1
1
1
28
Value (overall)
85
76
56
65

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Emeis with its peers
Attendo
STO:ATT
75
CountrySweden
IndustryHealth Care Providers & Services
SizeLarge
Full Stock Analysis →
Equasens
PAR:EQS
40
CountryFrance
IndustryHealth Care Technology
SizeSmall
Full Stock Analysis →
Philips
AEX:PHIA
71
CountryNetherlands
IndustryHealth Care Equipment & Supplies
SizeX-Large
Full Stock Analysis →
Camurus
STO:CAMX
83
CountrySweden
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Spire
LSE:SPI
38
CountryUK
IndustryHealth Care Providers & Services
SizeLarge
Full Stock Analysis →
Medicover
STO:MCOV B
21
CountryCyprus
IndustryHealth Care Providers & Services
SizeLarge
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →